When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
GMAB - Genmab reports Q1 net sales of $2.26B for DARZALEX
Genmab A/S
2023-04-18 07:32:23 ET
Genmab ( GMAB ) has reported worldwide Q1 net trade sales of $2.26B for DARZALEX (daratumumab) prescription medicine.
Net trade sales were $1.91B in the U.S. and $1.07B in the rest of the world.
Genmab receives royalties on the worldwide net sales of DARZALEX, both the intravenous and SC products, under the exclusive worldwide license to Janssen to develop, manufacture and commercialize daratumumab.